
Robust haemophilia study
Date: August 16, 2014
Service Description
To prepare a trial for a new formulation of a therapeutic haemophilia medicine, based on a freeze-dried coagulation factor.
What Went Well
The appropriate patient group was assembled; the trial was executed on time; reports and data analysis were appropriate and of good quality.
What Could Be Improved
There was nothing that could be improved, the service was good.
Lessons Learned from the Experience
The CRO provided helpful advice, especially in designing the study so it lent itself to robust statistical analysis.